<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/496B7214-5694-419C-AF23-78F025A48AF5"><gtr:id>496B7214-5694-419C-AF23-78F025A48AF5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Trowsdale</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0401569"><gtr:id>62F5968B-EC8C-4192-8350-DC090313EC83</gtr:id><gtr:title>Human Natural Killer cell-related receptors: diversity, ligands and disease susceptibility.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401569</gtr:grantReference><gtr:abstractText>Natural Killer Cells circulate in the blood. They have an important role in protection against infection and cancer. 
It is not well understood how Natural Killer Cells achieve the difficult task of attacking infected tissue but leaving normal tissues alone; it is suspected that receptor molecules on the surface of the cells play a critical role. One set of receptors, called KIR, differ dramatically from person to person. This striking feature provides clues to their functions in immune defence.
In view of this, our project has three aims:
To investigate the dramatic variation in KIR receptors from person to person.
To identify what different KIR receptors bind to on cells that they target; what are they receptors of?
To understand how variation in KIR receptors helps some people to be resistant to disease. 
By understanding how KIR receptors work we hope to be able to harness them to combat cancer and infection.</gtr:abstractText><gtr:technicalSummary>Natural killer (NK) cells have a critical role in protection against viruses and tumours. They express a wide variety of both inhibitory and activating receptors, some of which are expressed on other immune cells with a role in modulating immune responses. Some NK receptors, notably KIR, are highly polymorphic. It is not known what is driving this variation but it is highly likely to be shaped by disease. To address this hypothesis, this programme of research will focus on the diversity and functions of human NK receptor genes through three specific aims: 1. We will analyse comprehensively the striking polygeny and polymorphism of human NK receptor-related genes by mapping and sequencing a range of KIR haplotypes. 2. We will identify ligands for some key receptors, such as KIR3DL3 and the adjacent, related LILR loci. We will probe ways in which their counter-receptor binding and functions are affected by polymorphic variation. 3. We will investigate the relationship between receptor variation and expression with disease.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1000000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mary Carrington</gtr:description><gtr:id>86D8C314-141B-4201-8F64-D714E1C8FD2B</gtr:id><gtr:impact>PMID: 19959527
PMID: 18972110</gtr:impact><gtr:partnerContribution>Longstanding intellectual and scientific collaboration</gtr:partnerContribution><gtr:piContribution>This is a longstanding collaboration with Mary Carrington's laboratory. Carrington has spent two sabbaticals in my laboratory to help with data interpretation and experimental design</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>PRYSPRY domains</gtr:description><gtr:id>2D996777-AF38-46B8-BF30-0ED44EC6E9D4</gtr:id><gtr:impact>PMID: 17400754</gtr:impact><gtr:piContribution>We developed collaborative work with Leo James which led to the recent announcement on 'internal' antibodies.
The basic finding in my laboratory was that PRYSPRY domains from the TRIM21 protein bound to IgG. Leo has developed this idea further and we are continuing to collaborate</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>DD474F93-21B8-4D56-9A51-7A4C011A07C7</gtr:id><gtr:impact>presentation to 6th form biology class

positive feedback</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>6th form talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>AB37DB99-ED99-4E3E-9D5B-706B946D2905</gtr:id><gtr:impact>Talk to 6th formers on genetic engineering

Positive feedback</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>314505</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>MRC Headoffice</gtr:fundingOrg><gtr:fundingRef>MR/M020290/1</gtr:fundingRef><gtr:id>CB6D565E-CA3E-4377-B5F0-DB0C7860C1FC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1495128</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant G0901682</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5DA4C9B3-9828-4C53-81DD-289E1C6D6B80</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>We have developed a novel rapid high-throughput KIR typing system. The advice we have been given from our development office was that this would not be patentable but the best way forward was to licence the technique or to develop it as a national resource</gtr:description><gtr:id>313B058E-91E3-413C-BDDA-1335F96D8760</gtr:id><gtr:impact>We are discussing applications, if any and possible marketing strategies with Craig Taylor in Tissue Typing at Addenbrookes</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Rapid KIR typing and copy number determination</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Novel techniques to provide rapid KIR typing on genomic DNA. This has not been published yet - we will be releasing several papers in 2011 using the assay. We will be collaborating with other groups to evaluate its use in disease screening, including T1D with John Todd</gtr:description><gtr:id>6297E273-46DC-49C0-9A29-C684EC2AC9AC</gtr:id><gtr:impact>Still being refined. We are discussing with Craig Taylor in Tissue typing how we may develop and licence this assay.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>High-throughput copy number and genotyping of KIR</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F85BEC2C-1491-45A3-B42A-C829A603F79B"><gtr:id>F85BEC2C-1491-45A3-B42A-C829A603F79B</gtr:id><gtr:title>Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdbd992e8d889853595e4e32d97cd79c"><gtr:id>bdbd992e8d889853595e4e32d97cd79c</gtr:id><gtr:otherNames>Traherne JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C6629A8F-AB61-4653-AEEC-1C3A724B3706"><gtr:id>C6629A8F-AB61-4653-AEEC-1C3A724B3706</gtr:id><gtr:title>NK receptor interactions with MHC class I molecules in pregnancy.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12229f904bc1eb2c96397ee6cd925eaf"><gtr:id>12229f904bc1eb2c96397ee6cd925eaf</gtr:id><gtr:otherNames>Trowsdale J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DE72C8E-2938-4313-A6C7-E47AB937964D"><gtr:id>3DE72C8E-2938-4313-A6C7-E47AB937964D</gtr:id><gtr:title>Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/480571fcfa950c333146811874d42270"><gtr:id>480571fcfa950c333146811874d42270</gtr:id><gtr:otherNames>Bennett NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6DF3CBB8-3481-4553-AB77-D577505031F6"><gtr:id>6DF3CBB8-3481-4553-AB77-D577505031F6</gtr:id><gtr:title>Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86cce1a14686725f17e074cc6a315eb5"><gtr:id>86cce1a14686725f17e074cc6a315eb5</gtr:id><gtr:otherNames>Trundley A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC5AA62F-4613-4224-9B1A-3BFCE22FFD94"><gtr:id>DC5AA62F-4613-4224-9B1A-3BFCE22FFD94</gtr:id><gtr:title>Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cbf7beb99b707620843dd0f4807ced6a"><gtr:id>cbf7beb99b707620843dd0f4807ced6a</gtr:id><gtr:otherNames>Nedvetzki S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9FB362A-03B4-4B61-9F31-9EB4E8335182"><gtr:id>E9FB362A-03B4-4B61-9F31-9EB4E8335182</gtr:id><gtr:title>Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EDA28747-79FF-453B-951B-F7E21E45415A"><gtr:id>EDA28747-79FF-453B-951B-F7E21E45415A</gtr:id><gtr:title>Selective export of HLA-F by its cytoplasmic tail.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e1123cb45cb20562eb16fea6324e1a5"><gtr:id>1e1123cb45cb20562eb16fea6324e1a5</gtr:id><gtr:otherNames>Boyle LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/305B6EDF-ECE1-488E-9B4E-B45E210B4909"><gtr:id>305B6EDF-ECE1-488E-9B4E-B45E210B4909</gtr:id><gtr:title>Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C213321-EBED-4B81-AA05-00D217313786"><gtr:id>2C213321-EBED-4B81-AA05-00D217313786</gtr:id><gtr:title>Mother's little helpers: mechanisms of maternal-fetal tolerance.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12229f904bc1eb2c96397ee6cd925eaf"><gtr:id>12229f904bc1eb2c96397ee6cd925eaf</gtr:id><gtr:otherNames>Trowsdale J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1CC1BF8-2F6C-4B5B-BE8D-F15836096052"><gtr:id>E1CC1BF8-2F6C-4B5B-BE8D-F15836096052</gtr:id><gtr:title>The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad3d23f27ab7cb2fdbc4c653e15603f5"><gtr:id>ad3d23f27ab7cb2fdbc4c653e15603f5</gtr:id><gtr:otherNames>Brown DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C9F7132-EFF6-4A51-AC8F-C8F8F4C81C55"><gtr:id>9C9F7132-EFF6-4A51-AC8F-C8F8F4C81C55</gtr:id><gtr:title>Cutting edge: killer Ig-like receptors mediate &amp;quot;missing self&amp;quot; recognition in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f90d85c9729a19eb3777c4db419f7061"><gtr:id>f90d85c9729a19eb3777c4db419f7061</gtr:id><gtr:otherNames>van Bergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06B21E4C-1A0B-4DFC-92C6-41CB6DD859A0"><gtr:id>06B21E4C-1A0B-4DFC-92C6-41CB6DD859A0</gtr:id><gtr:title>Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/413eff2f4a5d4faf73a5ac9ea92f6a17"><gtr:id>413eff2f4a5d4faf73a5ac9ea92f6a17</gtr:id><gtr:otherNames>James LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1CCFD76-3303-49D5-B85B-1446FFACB7B0"><gtr:id>F1CCFD76-3303-49D5-B85B-1446FFACB7B0</gtr:id><gtr:title>Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7cc49ebda40b26816bfc58e82e089d43"><gtr:id>7cc49ebda40b26816bfc58e82e089d43</gtr:id><gtr:otherNames>Hov JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/604B95E3-E228-408B-905D-F6E9D847F844"><gtr:id>604B95E3-E228-408B-905D-F6E9D847F844</gtr:id><gtr:title>Selective export of HLA-F by its cytoplasmic tail.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e1123cb45cb20562eb16fea6324e1a5"><gtr:id>1e1123cb45cb20562eb16fea6324e1a5</gtr:id><gtr:otherNames>Boyle LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFC0BF2B-5C3A-4A49-8FD7-9D241E882AD8"><gtr:id>BFC0BF2B-5C3A-4A49-8FD7-9D241E882AD8</gtr:id><gtr:title>Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f847f4b27f8d030ac454b73428fe6f4"><gtr:id>3f847f4b27f8d030ac454b73428fe6f4</gtr:id><gtr:otherNames>Cao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/56B56A0F-FB16-4923-965C-E18066648B75"><gtr:id>56B56A0F-FB16-4923-965C-E18066648B75</gtr:id><gtr:title>Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e1123cb45cb20562eb16fea6324e1a5"><gtr:id>1e1123cb45cb20562eb16fea6324e1a5</gtr:id><gtr:otherNames>Boyle LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E3553DF-E4F3-48B2-B0D8-FE2C75D06618"><gtr:id>3E3553DF-E4F3-48B2-B0D8-FE2C75D06618</gtr:id><gtr:title>SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f847f4b27f8d030ac454b73428fe6f4"><gtr:id>3f847f4b27f8d030ac454b73428fe6f4</gtr:id><gtr:otherNames>Cao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBB8EA74-8CA5-487E-994B-3035EA49710E"><gtr:id>BBB8EA74-8CA5-487E-994B-3035EA49710E</gtr:id><gtr:title>HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D70B2FB3-7E14-440F-9691-EE61AB8C3905"><gtr:id>D70B2FB3-7E14-440F-9691-EE61AB8C3905</gtr:id><gtr:title>Interactions between human NK cells and macrophages in response to Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39527f1b3da905dfb5c6ba36108dce02"><gtr:id>39527f1b3da905dfb5c6ba36108dce02</gtr:id><gtr:otherNames>Lapaque N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA6F25F1-177A-40FB-BD69-2A68EEEB953A"><gtr:id>BA6F25F1-177A-40FB-BD69-2A68EEEB953A</gtr:id><gtr:title>The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a83780603d1b41bed8a7fcc5d79968c"><gtr:id>8a83780603d1b41bed8a7fcc5d79968c</gtr:id><gtr:otherNames>Horton R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3AF7D54-03B0-4B52-9248-DDD71A904963"><gtr:id>B3AF7D54-03B0-4B52-9248-DDD71A904963</gtr:id><gtr:title>A second major histocompatibility complex susceptibility locus for multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d0dd873a17d90dd4ab4afb0e831ac14"><gtr:id>3d0dd873a17d90dd4ab4afb0e831ac14</gtr:id><gtr:otherNames>Yeo TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41FB77D6-58ED-4A4E-81EF-71B9916EE45C"><gtr:id>41FB77D6-58ED-4A4E-81EF-71B9916EE45C</gtr:id><gtr:title>Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoform.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf37985b266f879d2e4eee3f503b1cc3"><gtr:id>bf37985b266f879d2e4eee3f503b1cc3</gtr:id><gtr:otherNames>Ohashi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2FD6C80-F43E-4FD4-BE50-650E0E95E1A9"><gtr:id>B2FD6C80-F43E-4FD4-BE50-650E0E95E1A9</gtr:id><gtr:title>Genetic variation, Fc? receptors, KIRs and infection: the evolution of autoimmunity.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14de6d29dc27003f41b59cb8262ac4ab"><gtr:id>14de6d29dc27003f41b59cb8262ac4ab</gtr:id><gtr:otherNames>Espeli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2642B997-6B76-47B7-A7F7-4A74B0E4C7C4"><gtr:id>2642B997-6B76-47B7-A7F7-4A74B0E4C7C4</gtr:id><gtr:title>Anaesthetic impairment of immune function is mediated via GABA(A) receptors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cebaf8dd1ad1e37139d648ef6a3f3b48"><gtr:id>cebaf8dd1ad1e37139d648ef6a3f3b48</gtr:id><gtr:otherNames>Wheeler DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C02E6F44-CF50-41E9-8B32-4077C205E4D1"><gtr:id>C02E6F44-CF50-41E9-8B32-4077C205E4D1</gtr:id><gtr:title>Molecular characterization of KIR3DL3.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a4a43a687a0bb7eb6799e3848efafe7"><gtr:id>3a4a43a687a0bb7eb6799e3848efafe7</gtr:id><gtr:otherNames>Trundley AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0E9DB35-9043-4DAD-85D5-16949D9B1363"><gtr:id>E0E9DB35-9043-4DAD-85D5-16949D9B1363</gtr:id><gtr:title>The extended human leukocyte receptor complex: diverse ways of modulating immune responses.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e5ba539ca40e58fd10ec114f920a1da"><gtr:id>4e5ba539ca40e58fd10ec114f920a1da</gtr:id><gtr:otherNames>Barrow AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67FD2C79-A570-4B81-8ED2-9E54CBE9C2CD"><gtr:id>67FD2C79-A570-4B81-8ED2-9E54CBE9C2CD</gtr:id><gtr:title>KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b67214e0f00849c74780105b6cad7dd"><gtr:id>7b67214e0f00849c74780105b6cad7dd</gtr:id><gtr:otherNames>Qi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/541A0663-49FE-4A7F-9854-134CFFD3648F"><gtr:id>541A0663-49FE-4A7F-9854-134CFFD3648F</gtr:id><gtr:title>The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5d96ebd071beead8c188eab50be432d"><gtr:id>b5d96ebd071beead8c188eab50be432d</gtr:id><gtr:otherNames>Young NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/705E7EC2-2E71-4EE9-9696-C00D3D6B0D80"><gtr:id>705E7EC2-2E71-4EE9-9696-C00D3D6B0D80</gtr:id><gtr:title>You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e5ba539ca40e58fd10ec114f920a1da"><gtr:id>4e5ba539ca40e58fd10ec114f920a1da</gtr:id><gtr:otherNames>Barrow AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75A5A379-7560-41FC-A98A-7D9C03F13638"><gtr:id>75A5A379-7560-41FC-A98A-7D9C03F13638</gtr:id><gtr:title>KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5636fd7d08ff0597b33a4daa04eaf8b"><gtr:id>d5636fd7d08ff0597b33a4daa04eaf8b</gtr:id><gtr:otherNames>Martin MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401569</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>